Your browser doesn't support javascript.
loading
Erratum to: Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation.
Epstein-Peterson, Zachary D; Drill, Esther; Aypar, Umut; Batlevi, Connie Lee; Caron, Philip; Dogan, Ahmet; Drullinsky, Pamela; Gerecitano, John; Hamlin, Paul A; Ho, Caleb; Jacob, Allison; Joseph, Ashlee; Laraque, Leana; Matasar, Matthew J; Moskowitz, Alison J; Moskowitz, Craig H; Mullins, Chelsea; Owens, Colette; Salles, Gilles; Schöder, Heiko; Straus, David J; Younes, Anas; Zelenetz, Andrew D; Kumar, Anita.
Afiliação
  • Epstein-Peterson ZD; Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Drill E; Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Aypar U; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Batlevi CL; Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Caron P; Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Dogan A; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Drullinsky P; Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Gerecitano J; Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Hamlin PA; Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Ho C; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Jacob A; Adaptive Biotechnologies, Seattle, WA.
  • Joseph A; Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Laraque L; Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Matasar MJ; Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Moskowitz AJ; Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Moskowitz CH; Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Mullins C; Adaptive Biotechnologies, Seattle, WA.
  • Owens C; Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Salles G; Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Schöder H; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Straus DJ; Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Younes A; Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Zelenetz AD; Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Kumar A; Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. kumara@mskcc.org.
Haematologica ; 109(8): 2749-2752, 2024 08 01.
Article em En | MEDLINE | ID: mdl-39087412

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasia Residual / Linfoma de Célula do Manto / Lenalidomida Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasia Residual / Linfoma de Célula do Manto / Lenalidomida Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article